Guo J - Search Results

1

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.

Ma B, Zhou Y, Shang Y, Zhang Y, Xu B, Fu X, Guo J, Yang Y, Zhang F, Zhou M, Huang H, Li F, Lin H, Zhao L, Wang Z, Gao Q. Ma B, et al. Among authors: guo j. Front Oncol. 2022 Sep 9;12:852885. doi: 10.3389/fonc.2022.852885. eCollection 2022. Front Oncol. 2022. PMID: 36158690 Free PMC article.

2

T Cells Expanded from PD-1⁺ Peripheral Blood Lymphocytes Share More Clones with Paired Tumor-Infiltrating Lymphocytes.

Li T, Zhao L, Yang Y, Wang Y, Zhang Y, Guo J, Chen G, Qin P, Xu B, Ma B, Zhang F, Shang Y, Li Q, Zhang K, Yuan D, Feng C, Ma Y, Liu Z, Tian Z, Li H, Wang S, Gao Q. Li T, et al. Among authors: guo j. Cancer Res. 2021 Apr 15;81(8):2184-2194. doi: 10.1158/0008-5472.CAN-20-2300. Epub 2021 Jan 6. Cancer Res. 2021. PMID: 33408117

3

High Complete Response Rate in Patients With Metastatic Renal Cell Carcinoma Receiving Autologous Cytokine-Induced Killer Cell Therapy Plus Anti-Programmed Death-1 Agent: A Single-Center Study.

Zhao L, Li T, Song Y, Yang Y, Ma B, Zhang Y, Shang Y, Xu B, Guo J, Qin P, Han L, Fu X, Lin H, Liu L, Ren X, Wang Z, Gao Q. Zhao L, et al. Among authors: guo j. Front Immunol. 2022 Jan 4;12:779248. doi: 10.3389/fimmu.2021.779248. eCollection 2021. Front Immunol. 2022. PMID: 35058923 Free PMC article. Clinical Trial.

4

Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinoma.

Li C, Zhang B, Guo J, Hu F, Nie W, Zheng X, Wang L, Lou Y, Shen Y, Han B, Zhang X. Li C, et al. Among authors: guo j. Target Oncol. 2019 Aug;14(4):423-431. doi: 10.1007/s11523-019-00649-1. Target Oncol. 2019. PMID: 31270661

5

Postoperative tumor bed radiation versus T-shaped field radiation in the treatment of locally advanced thoracic esophageal squamous cell carcinoma: a phase IIb multicenter randomized controlled trial.

Zeng Y, Li J, Ye J, Han G, Luo W, Wu C, Qin S, Gu W, Zhao S, Zhao Y, Xia B, Zhu Z, Du X, Liu Y, Liu J, Li H, Wang J, Guo J, Yu W, Zhang Q, Wang C, Fang W, Li Z, Fu X, Cai X. Zeng Y, et al. Among authors: guo j. BMC Med. 2024 Nov 7;22(1):522. doi: 10.1186/s12916-024-03727-y. BMC Med. 2024. PMID: 39511550 Free PMC article. Clinical Trial.

6

PD-L1 expression and its correlation with clinicopathological and molecular characteristics in Chinese patients with non-small cell lung cancer.

Guo J, Yuan H, Zhu Y, Che Z, Zhang B, Zhang D, Zhou Y, Xiong L. Guo J, et al. Medicine (Baltimore). 2024 Feb 23;103(8):e36770. doi: 10.1097/MD.0000000000036770. Medicine (Baltimore). 2024. PMID: 38394518 Free PMC article.

7

A real-world analysis of stereotactic body radiotherapy combined with immunotherapy in advanced or recurrent non-small cell lung cancer (NSCLC): A single-center experience.

Yao D, Zhu X, Guo J, Dong X, Zeng Y, Fu X, Yu W. Yao D, et al. Among authors: guo j. Clin Transl Radiat Oncol. 2024 May 1;47:100787. doi: 10.1016/j.ctro.2024.100787. eCollection 2024 Jul. Clin Transl Radiat Oncol. 2024. PMID: 38770061 Free PMC article.

8

Correction to: Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung Adenocarcinoma.

Li C, Zhang B, Guo J, Hu F, Nie W, Zheng X, Wang L, Lou Y, Shen Y, Han B, Zhang X. Li C, et al. Among authors: guo j. Target Oncol. 2019 Aug;14(4):491. doi: 10.1007/s11523-019-00659-z. Target Oncol. 2019. PMID: 31317306

9

Additional local consolidative therapy has survival benefit over EGFR tyrosine kinase inhibitors alone in bone oligometastatic lung adenocarcinoma patients.

Hu F, Li C, Xu J, Guo J, Shen Y, Nie W, Zheng X, Wang L, Zhang H, Han B, Zhang X. Hu F, et al. Among authors: guo j. Lung Cancer. 2019 Sep;135:138-144. doi: 10.1016/j.lungcan.2019.07.024. Epub 2019 Jul 24. Lung Cancer. 2019. PMID: 31446986

10

Analyses of distribution and dosimetry of brain metastases in small cell lung cancer with relation to the neural stem cell regions: feasibility of sparing the hippocampus in prophylactic cranial irradiation.

Zhao L, Shen Y, Guo JD, Gu HL, Yu W, Wang JM, Lv CX, Liu J, Cai XW, Fu XL. Zhao L, et al. Among authors: guo jd. Radiat Oncol. 2017 Jul 15;12(1):118. doi: 10.1186/s13014-017-0855-3. Radiat Oncol. 2017. PMID: 28709456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,463 results

Search Page

Filters